研究
2015以前 研究業績・論文発表
論文
Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, Teshigawara K, Haruma J, Yamamoto Y, Yamamoto H, Date I, Takahashi HK, Mori S, Nishibori M.
Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
Neuropharmacology. 2014 Oct;85:18-26.
GlycyrrhizinのHMGB1誘導性脳外傷後障害の抑制効果の検討
Nishibori M, Takahashi H.
[Discovery of drugs targeting HMGB1-RAGE system].
Nihon Yakurigaku Zasshi. 2014 Jan;143(1):3.
HMGB1-RAGEシステムを標的にした新薬開発の基礎的検討
Okuma Y, Liu K, Wake H, Zhang J, Maruo T, Date I, Yoshino T, Ohtsuka A, Otani N, Tomura S, Shima K, Yamamoto Y, Yamamoto H, Takahashi HK, Mori S, Nishibori M.
Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
Ann Neurol. 2012 Sep;72(3):373-84.
脳外傷後障害へのHMGB1の関与の検討
Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T, Ohtsuka A, Mori S, Nishibori M.
Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
Stroke. 2011 May;42(5):1420-8.
脳梗塞後障害へのHMGB1の関与の検討